Most dividend investing content focuses almost entirely on US stocks. And while there are excellent dividend growers in America, some of the most reliable, growing dividend payers in the world sit right here in Europe, quietly compounding away, largely ignored by the English-language investing community.

At Dividend Talk, we cover both sides of the Atlantic. And with over 100 stocks in our research library, we’ve done the heavy lifting to bring you our top 10 European picks for 2026, screened for dividend safety scores, valuation, and long-term dividend growth.

Whether you’re based in Europe or looking to add international diversification to a US-heavy portfolio, this list is for you.

#	Stock	Country	Safety Score	Valuation	Yield
1	Wolters Kluwer	Netherlands	Very Safe	Undervalued	3.75%
2	ASR Nederland	Netherlands	Very Safe	Undervalued	5.93%
3	Munich Re	Germany	Very Safe	Fairly Valued	4.61%
4	NN Group	Netherlands	Very Safe	Fairly Valued	5.91%
5	Fuchs Petrolub	Germany	Very Safe	Fairly Valued	4.11%
6	London Stock Exchange	UK	Safe	Undervalued	1.72%
7	Novo Nordisk	Denmark	Safe	Undervalued	6.44%
8	RELX PLC	UK	Safe	Fairly Valued	2.69%
9	Sanofi	France	Safe	Undervalued	5.39%

How We Selected These Stocks

Every stock in the Dividend Talk library is assessed on several factors. For this list, our priority order was:

1. Dividend Safety Score — our in-house score assessing dividend sustainability, balance sheet strength, and business quality
2. Valuation — we favoured Undervalued and Fairly Valued stocks over those trading at a premium
3. European listing first — companies headquartered and primarily listed in Europe
4. Dividend track record and growth rate — we want growers, not just high yielders

We are not chasing the highest yield. A 9% yield that gets cut in two years is worth nothing. We want dividends that grow reliably, year after year.

1. Wolters Kluwer (WKL.AS) — Netherlands

Sector: Industrials / Information Services Dividend Yield: 3.75% | 5-Year CAGR: 9.93% | Streak: 36 years | Valuation: Undervalued

Wolters Kluwer is one of Europe’s most consistent dividend growers and one of the most underappreciated names in our entire library. It provides professional information, software, and services to lawyers, accountants, finance professionals, and healthcare providers worldwide.

What makes it compelling in 2026 is the combination of a 36-year dividend growth streak, a nearly 10% five-year dividend CAGR, and, crucially, an Undervalued rating at current prices. This is not a stock you often find on sale.

The business is highly recurring-revenue driven, which gives dividend sustainability a strong foundation. For long-term dividend growth investors, Wolters Kluwer is one of the cleanest stories on this list.

Want the full deep dive? Wolters Kluwer is covered in detail in our stock card library →

2. ASR Nederland (ASRNL.AS) — Netherlands

Sector: Financial Services (Insurance) Dividend Yield: 5.93% | 5-Year CAGR: 7.10% | Streak: 10 years | Valuation: Undervalued

ASR Nederland is a Dutch insurer that offers something rare: a nearly 6% yield on a stock we rate as Undervalued. That combination doesn’t come around often.

With 10 consecutive years of dividend growth and a 7% five-year CAGR, this is not a yield trap. The insurance business generates strong, predictable cash flows, and management is clearly committed to growing shareholder returns.

If you’re building a European dividend income portfolio and want meaningful yield with growth, ASR deserves serious consideration in 2026.

3. Munich Re (MUV2.DE) — Germany

Sector: Financial Services (Reinsurance) Dividend Yield: 4.61% | 5-Year CAGR: 16.89% | Streak: 53 years | Valuation: Fairly Valued

Fifty-three consecutive years of dividend payments without a cut. Let that sink in.

Munich Re is one of Europe’s true dividend aristocrats, a global reinsurance giant with the financial firepower to grow its dividend through every economic cycle since the early 1970s. The 16.89% five-year dividend CAGR is exceptional for a business this size and this mature.

At a Fairly Valued rating, it is not cheap, but for a 53-year dividend grower with the quality Munich Re represents, that is entirely reasonable. This is a core holding in any serious European dividend portfolio.

4. NN Group (NN.AS) — Netherlands

Sector: Financial Services (Insurance) Dividend Yield: 5.91% | 5-Year CAGR: 9.28% | Streak: 11 years | Valuation: Fairly Valued

Another Dutch insurer on the list, and for good reason. The Dutch financial sector consistently produces some of the most attractive income opportunities in Europe.

NN Group offers a nearly 6% yield with 9.28% five-year dividend growth and a Fairly Valued assessment. The business is well-capitalised, focused on life insurance and asset management across Europe, and has a clear shareholder return policy.

Paired with ASR, NN Group gives you meaningful exposure to the Dutch insurance market — one of the most dividend-friendly sectors on the continent.

5. Fuchs Petrolub SE (FPE.DE) — Germany

Sector: Basic Materials (Specialty Chemicals / Lubricants) Dividend Yield: 4.11% | Streak: 31 years | Valuation: Fairly Valued

Fuchs Petrolub is not a household name outside of industrial circles, and that’s exactly why it belongs on this list. This German lubricants specialist has quietly grown or maintained its dividend for 31 consecutive years, making it one of the longest-running dividend growth streaks in European mid-cap territory.

The business supplies lubricants to the automotive, industrial, and metalworking sectors globally. It is a niche but durable market position. At a Fairly Valued rating and a 4%+ yield, this is the kind of boring, reliable compounder that forms the backbone of a strong dividend portfolio.

6. London Stock Exchange Group (LSEG.L) — UK

Sector: Financial Services (Data & Infrastructure) Dividend Yield: 1.72% | 5-Year CAGR: 9.57% | Streak: 22 years | Valuation: Undervalued

The yield is modest, but the picture here is all about growth and quality. LSEG has transformed from a traditional stock exchange into a global financial data and analytics powerhouse following its acquisition of Refinitiv. Twenty-two years of consecutive dividend growth, a 9.57% five-year CAGR, and an Undervalued rating make this a compelling long-term compounder.

If you are in the early stages of building your portfolio and reinvesting dividends, LSEG’s combination of growth, quality, and current undervaluation makes it an interesting long-term holding.

7. Novo Nordisk (NOVO-B) — Denmark

Sector: Healthcare (Pharmaceuticals / GLP-1) Dividend Yield: 6.44% | 5-Year CAGR: 25.05% | Streak: 32 years | Valuation: Undervalued

Novo Nordisk is one of the most discussed pharmaceutical companies in the world right now, and for good reason. Its GLP-1 drugs, including Ozempic and Wegovy, have fundamentally shifted the global obesity and diabetes treatment market.

For dividend investors, the story is equally interesting: 32 consecutive years of dividend growth, a 25% five-year CAGR, a 6.44% yield, and an Undervalued rating in early 2026. The sharp share price pullback from its 2024 peaks has created an unusually attractive entry point for income investors.

This is the rare case of a world-class growth business that also happens to be a serious dividend grower.

8. RELX PLC (REL.L) — UK

Sector: Industrials (Data Analytics / Publishing) Dividend Yield: 2.69% | 5-Year CAGR: 7.35% | Streak: 26 years | Valuation: Fairly Valued

RELX is one of the UK’s most consistent dividend growth stories. A data analytics and professional information company serving the legal, scientific, and risk management industries. Twenty-six years of consecutive growth and a 7.35% five-year CAGR underline the reliability of its payouts.

The yield is moderate, but the quality of the underlying business is high. RELX has significant pricing power and deeply embedded customer relationships. For investors who prioritise business durability over short-term income, this is a blue-chip European compounder.

9. Sanofi (SAN.PA) — France

Sector: Healthcare (Pharmaceuticals) Dividend Yield: 5.39% | 5-Year CAGR: 4.35% | Streak: 24 years | Valuation: Undervalued

Sanofi rounds out our list as a French pharmaceutical giant offering a rare combination of a 5%+ yield, 24 years of consecutive dividend growth, and an Undervalued rating. While its dividend growth rate is more measured than some others here, the combination of yield, safety, and valuation makes it an attractive income holding for 2026.

It is one of Europe’s largest drug makers with a diverse portfolio spanning immunology, oncology, and rare diseases, providing the earnings breadth needed to sustain dividends across market cycles.

Honourable Mentions

These stocks scored highly on our safety model but are currently assessed as Overvalued, which tempers their attractiveness at current prices. They are worth adding to your watchlist for a better entry:

• ASML Holding (Netherlands) — The semiconductor equipment monopoly. Phenomenal business, poor valuation today.
• Halma PLC (UK) — A serial acquirer of safety and environmental technology businesses. One of the UK’s best compounders, but richly priced.
• Schneider Electric (France) — Energy management and automation. Excellent business, but trading at a premium.
• Iberdrola (Spain) — . Europe’s largest renewable energy utility. Solid dividend history, currently overvalued.

Building Your European Dividend Portfolio

A list is only as useful as the action you take with it. A few principles to keep in mind:

Don’t over-concentrate. Several stocks above are in the financial services sector. Diversify across sectors so that one industry downturn doesn’t hit your entire income stream.

Yield is not the only metric. A 5% yield growing at 8% per year will likely deliver more income in 10 years than a 7% yield that stagnates. Think about where your income will be in a decade, not just today.

Reinvest while you can. If you don’t need the income yet, reinvesting dividends in Undervalued names on this list accelerates compounding significantly.

New to dividend investing in Europe? Before acting on any of these picks, make sure you understand the fundamentals. Our beginhttps://dividendtalkpodcast.com/dividend-growth-investing-for-beginners/ner’s guide to dividend investing in Europe → covers everything you need to know.

Get the Full Data Behind These Picks

Every stock on this list is part of the Dividend Talk stock card library — over 100 stocks with safety scores, valuation assessments, dividend history, payout ratios, and key metrics updated regularly.

Explore the full stock card library →

FAQ

DISCLAIMER:Dividend Talk is not a licensed or registered investment adviser or broker/dealer. We are not providing you with individual investment advice on this site. Please consult with a licensed investment professional before you invest your money. This site is for entertainment, informational, and educational use only.Any opinion expressed on the site here and elsewhere on the internet is not a form of investment advice provided to you. We use information, data, and sources in the articles we believe to be correct at the time of writing them, but there is no guarantee of their accuracy, completeness, timeliness, or correctness. We are not liable for any losses suffered by any party because of information published on this site. Past performance is not a guarantee of future performance. By reading this site or subscribing to it, you agree that you are solely responsible for making investment decisions with your funds.